Sphere 3D Corp. (ANY) Reaches $0.52 1 Year Low; Shorts at CANNABIS SCIENCE (CBIS) Lowered By 5.95%

April 20, 2018 - By Migdalia James

Cannabis Science, Inc. (OTCMKTS:CBIS) Logo

CANNABIS SCIENCE INC (OTCMKTS:CBIS) had a decrease of 5.95% in short interest. CBIS’s SI was 210,200 shares in April as released by FINRA. Its down 5.95% from 223,500 shares previously. The SI to CANNABIS SCIENCE INC’s float is 0.01%. The stock 7.14% or $0 during the last trading session, reaching $0.06. It is down 0.00% since April 20, 2017 and is . It has underperformed by 11.55% the S&P500.

The stock of Sphere 3D Corp. (NASDAQ:ANY) hit a new 52-week low and has $0.48 target or 9.00% below today’s $0.52 share price. The 6 months bearish chart indicates high risk for the $6.68M company. The 1-year low was reported on Apr, 20 by Barchart.com. If the $0.48 price target is reached, the company will be worth $601,110 less. The stock decreased 3.55% or $0.0192 during the last trading session, reaching $0.5224. About 285,017 shares traded. Sphere 3D Corp. (NASDAQ:ANY) has declined 82.21% since April 20, 2017 and is downtrending. It has underperformed by 93.76% the S&P500.

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid pharmaceutical products primarily in the United States. The company has market cap of $153.11 million. The firm is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. It currently has negative earnings. The Company’s drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis therapy for neurological conditions.

Investors sentiment decreased to 1.33 in Q4 2017. Its down 6.67, from 8 in 2017Q3. It dived, as 3 investors sold Cannabis Science, Inc. shares while 0 reduced holdings. 3 funds opened positions while 1 raised stakes. 277,539 shares or 8.94% less from 304,780 shares in 2017Q3 were reported. Neville Rodie Shaw owns 170,000 shares or 0% of their US portfolio. Rothschild Inv Il owns 14,000 shares. Silvercrest Asset Management Gru Ltd Co accumulated 10,000 shares or 0% of the stock. Churchill holds 13,389 shares or 0% of its portfolio. Massmutual Trust Fsb Adv invested in 0% or 150 shares. Frontier Invest holds 20,000 shares or 0% of its portfolio. North Star Asset Management Inc has 0% invested in Cannabis Science, Inc. (OTCMKTS:CBIS) for 40,000 shares. Minnesota-based Stonebridge Cap Lc has invested 0% in Cannabis Science, Inc. (OTCMKTS:CBIS).

Sphere 3D Corp. provides virtualization technologies and data management solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $6.68 million. It enables organizations to deploy a combination of public, private, or hybrid cloud strategies through containerized applications, virtual desktops, virtual storage, and physical hyper-converged platforms. It currently has negative earnings. The firm offers G-Series Appliance and G-Series Cloud applications; virtual desktop management software for managing virtual desktop pools on its V3 hyper-converged appliances for virtualized desktop infrastructures; virtual desktop infrastructure appliances; RDX removable disk solutions, which use public cloud providers comprising Microsoft and Amazon for data protection; and SnapServer network attached storage solution, a platform for primary or nearline storage for integration with Windows, UNIX/Linux, and Macintosh environments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.